Share

Networks

Clinical Studies (7)

  • Prüßler : Study aims to assess clinical improvement in patients with chronic fatigue syndrome and post-acute COVID-19 syndrome three months after the completion of immunoadsorption
  • Bellmann-Strobl : Study aims to demonstrate improvement in physical function measured using the short form-36 health questionnaire in patients with post-COVID-19 syndrome treated with Vericiguat compared with placebo
  • Scheibenbogen : Study aims to assess symptom outcome and functional ability in 20 patients with post COVID syndrome meeting myalgic encephalomyelitis/chronic fatigue syndrome diagnostic criteria with elevated ß2R antibodies undergoing antibody depletion by immunoadsorption
  • Ismail : Study aims to understand the impact of statins on COVID-19-related inflammation and to investigate the association between prior statin use and the composite outcome of in-hospital death, need for mechanical ventilation, and need for renal replacement therapy in patients hospitalized for COVID-19
  • Zeyen : Study aims to investigate disease characteristics during the initial infection and to assess long-term sequelae, including scarring and quality of life, at 4-6 months after initial infection
  • Franke : Study aims to investigate the impact of methylprednisolone on cognitive deficits in patients with post-COVID-19 syndrome. To evaluate improvement in memory function in patients treated with methylprednisolone compared with placebo
  • BLOC : Study aims to investigate the efficacy, pharmacodynamics and safety of BC 007 in improving long COVID symptoms by neutralising functional autoantibodies targeting G-protein

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Monkeypox virus
  • Post COVID-19 condition
  • Acute COVID-19
  • Mpox
  • Pharmacological intervention
  • Non pharmacological intervention
  • Immunoadsorption
  • Corticosteroid
  • Methylprednisolone
  • Statins
  • BC 007
  • vasodilator
  • Vericiguat

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to